RUNX1
Runt-related transcription factor 1
Also known as: AML1, AMLCR1, CBFA2, PEBP2A2, RUNX1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q01196
- Gene
- RUNX1
- Ensembl
- ENSG00000159216
- Chromosome
- 21
- Canonical length
- 453 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
453 residues, UniProt reviewed canonical sequence.
>Q01196|RUNX1
1 MRIPVDASTS RRFTPPSTAL SPGKMSEALP LGAPDAGAAL AGKLRSGDRS MVEVLADHPG
61 ELVRTDSPNF LCSVLPTHWR CNKTLPIAFK VVALGDVPDG TLVTVMAGND ENYSAELRNA
121 TAAMKNQVAR FNDLRFVGRS GRGKSFTLTI TVFTNPPQVA TYHRAIKITV DGPREPRRHR
181 QKLDDQTKPG SLSFSERLSE LEQLRRTAMR VSPHHPAPTP NPRASLNHST AFNPQPQSQM
241 QDTRQIQPSP PWSYDQSYQY LGSIASPSVH PATPISPGRA SGMTTLSAEL SSRLSTAPDL
301 TAFSDPRQFP ALPSISDPRM HYPGAFTYSP TPVTSGIGIG MSAMGSATRY HTYLPPPYPG
361 SSQAQGGPFQ ASSPSYHLYY GASAGSYQFS MVGGERSPPR ILPPCTNAST GSALLNPSLP
421 NQSDVVEAEG SHSNSPTNMA PSARLEEAVW RPYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RUNX1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 43 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 43 nTPM
- salivary gland: 37 nTPM
- thymus: 26 nTPM
- breast: 25 nTPM
- lung: 21 nTPM
- urinary bladder: 19 nTPM
Single-cell type
- salivary duct cells: 1,812 nCPM
- hematopoietic stem cells: 1,603 nCPM
- megakaryocyte progenitors: 1,573 nCPM
- neutrophil progenitors: 1,515 nCPM
- megakaryocyte-erythroid progenitors: 1,466 nCPM
- salivary basal cells: 1,412 nCPM
Immune cell
- basophil: 24 nTPM
- eosinophil: 7.1 nTPM
- non-classical monocyte: 4.8 nTPM
- T-reg: 4.6 nTPM
- naive CD4 T-cell: 4.5 nTPM
- memory B-cell: 4.2 nTPM
Brain region
- thalamus: 23 nTPM
- white matter: 20 nTPM
- pons: 17 nTPM
- medulla oblongata: 16 nTPM
- choroid plexus: 14 nTPM
- spinal cord: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RUNX1.
Disease | AllUniProt
Conditions RUNX1 is implicated in, by any mechanism.
- Familial platelet disorder with associated myeloid malignancy (FPDMM) MIM:601399
Disease | GeneticClinVar
247 pathogenic / likely-pathogenic of 1,870 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hereditary thrombocytopenia and hematologic cancer predisposition syndrome
- Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1
- Inborn genetic diseases
- Thrombocytopenia
- Acute myeloid leukemia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.65
- gnomAD missense Z
- 2
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cardiac muscle tissue regeneration
- chondrocyte differentiation
- hematopoietic stem cell proliferation
- hemopoiesis
- myeloid cell differentiation
- myeloid leukocyte differentiation
- negative regulation of CD4-positive, alpha-beta T cell differentiation
- negative regulation of granulocyte differentiation
- negative regulation of transcription by RNA polymerase II
- neuron differentiation
- ossification
- peripheral nervous system neuron development
- positive regulation of angiogenesis
- positive regulation of CD8-positive, alpha-beta T cell differentiation
- positive regulation of collagen biosynthetic process
- positive regulation of DNA-templated transcription
- positive regulation of extracellular matrix organization
- positive regulation of granulocyte differentiation
- positive regulation of interleukin-2 production
- positive regulation of transcription by RNA polymerase II
- regulation of cardiac muscle cell proliferation
- regulation of cell differentiation
- regulation of plasminogen activation
- regulation of transcription by RNA polymerase II
- regulation of connective tissue replacement
Molecular functions
- ATP binding
- calcium ion binding
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor binding
- protein heterodimerization activity
- protein homodimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- transcription cis-regulatory region binding
- transcription coactivator binding
- transcription corepressor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Acute myeloid leukemia 1 protein (AML1)/Runt
- p53-like transcription factor, DNA-binding domain superfamily
- p53/RUNT-type transcription factor, DNA-binding domain superfamily
- Runt domain
- Runx, C-terminal domain
- Runt-related transcription factor RUNX
- Runx, central domain superfamily
- Runt domain
- Runx inhibition domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RUNX1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RUNX1 as an antibody target. Whether an autoantibody or antibody against RUNX1 could matter depends on whether native RUNX1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RUNX1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RUNX1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...